UCSF

UCSF School of Pharmacy leads in NIH funding for 34th year in a row

For the 34th consecutive year, the UCSF School of Pharmacy has received more research funding from the National Institutes of Health (NIH) than any other pharmacy school in the United States.

School researchers were awarded $29.2 million during the 2013 NIH fiscal year, from October 1, 2012 to September 30, 2013.

“Thirty-plus years of top NIH funding is an accomplishment to celebrate,” said School of Pharmacy Dean B. Joseph Guglielmo, PharmD. “Yet while we look back with pride, we also look forward to an even brighter future.

“This year marked the fourth in a row in which our junior faculty members received the highly selective NIH Director’s New Innovator Award,” noted Guglielmo. “This prestigious award provides millions of dollars for ‘exceptionally innovative’ research. This year’s awardee was Zev Gartner, PhD, the developer of a revolutionary technology toward the construction of complex 3-D human tissues and associated study of biology and therapeutics.”

More

UCSF Schools Leads the Nation in NIH Biomedical Research Funds


About the School: The UCSF School of Pharmacy aims to solve the most pressing health care problems and strives to ensure that each patient receives the safest, most effective treatments. Our discoveries seed the development of novel therapies, and our researchers consistently lead the nation in NIH funding. The School’s doctor of pharmacy (PharmD) degree program, with its unique emphasis on scientific thinking, prepares students to be critical thinkers and leaders in their field.